Your browser is no longer supported. Please, upgrade your browser.
SBOT Stellar Biotechnologies, Inc. monthly Stock Chart
SBOT [NASD]
Stellar Biotechnologies, Inc.
Index- P/E- EPS (ttm)-0.51 Insider Own5.90% Shs Outstand10.36M Perf Week-11.21%
Market Cap9.84M Forward P/E- EPS next Y-0.38 Insider Trans- Shs Float7.87M Perf Month-10.60%
Income-5.20M PEG- EPS next Q-0.11 Inst Own2.60% Short Float0.73% Perf Quarter-18.09%
Sales0.50M P/S19.69 EPS this Y13.70% Inst Trans-1.10% Short Ratio1.00 Perf Half Y-16.66%
Book/sh0.85 P/B1.12 EPS next Y19.10% ROA-47.00% Target Price2.00 Perf Year-54.32%
Cash/sh0.73 P/C1.30 EPS next 5Y- ROE-49.30% 52W Range0.89 - 2.22 Perf YTD-53.20%
Dividend- P/FCF- EPS past 5Y16.20% ROI-70.60% 52W High-57.20% Beta1.12
Dividend %- Quick Ratio18.80 Sales past 5Y-4.40% Gross Margin-28.40% 52W Low6.75% ATR0.07
Employees23 Current Ratio19.10 Sales Q/Q-99.00% Oper. Margin- RSI (14)31.27 Volatility11.56% 6.60%
OptionableNo Debt/Eq0.00 EPS Q/Q15.00% Profit Margin- Rel Volume0.45 Prev Close0.91
ShortableYes LT Debt/Eq0.00 EarningsDec 13 AMC Payout- Avg Volume57.80K Price0.95
Recom2.00 SMA20-12.63% SMA50-15.56% SMA200-25.29% Volume26,199 Change4.97%
Dec-02-16Reiterated Maxim Group Buy $7 → $4
Aug-01-16Reiterated Maxim Group Buy $17 → $7
Dec-06-17 11:00AM  SBOT: Important Clinical Program Related Milestones Upcoming Zacks Small Cap Research
Dec-05-17 11:00AM  Stellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: 2017 By the Numbers : December 5, 2017 Capital Cube
Dec-01-17 08:00AM  Stellar Biotechnologies Reports Fiscal Year 2017 Financial Results PR Newswire +6.17%
Nov-30-17 12:15PM  SBOT: Neovacs' Ph IIb Lupus Study Could Read-Out 1H 2018 Zacks Small Cap Research
Nov-29-17 08:30AM  Stellar Biotechnologies to Present at the LD Micro Main Event Investor Conference PR Newswire
Oct-17-17 09:11PM  Should You Buy Stellar Biotechnologies Inc (SBOT) Now? Simply Wall St.
Sep-05-17 09:00AM  SBOT: Neovacs Ph 2 Lupus Study Completes Enrollment. Read-Out Q2 2018 Zacks Small Cap Research
Aug-24-17 11:40AM  Stellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: Q3, 2017 By the Numbers : August 24, 2017 Capital Cube
Aug-09-17 04:05PM  Stellar Biotechnologies Reports Third Quarter 2017 Financial Results PR Newswire
Jun-07-17 08:30AM  Stellar Biotechnologies Expands Operations Team PR Newswire
Jun-02-17 10:02AM  Stellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: Q2, 2017 By the Numbers : June 2, 2017 Capital Cube
May-31-17 08:15AM  Stellar Biotechnologies to Present at Marcum Investor Conference PR Newswire
May-26-17 09:00AM  SBOT: Clinical Trial Progression Remains Key Metric Zacks Small Cap Research
May-09-17 04:15PM  Stellar Biotechnologies Reports Second Quarter 2017 Financial Results PR Newswire
Mar-29-17 06:03AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to
Mar-20-17 11:58AM  Stellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: Q1, 2017 By the Numbers : March 20, 2017 Capital Cube
11:58AM  Stellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: Q1, 2017 By the Numbers : March 20, 2017
Mar-14-17 08:00AM  Why Valeant, Tesla, Citrix Systems, Ruby Tuesday, and Stellar Biotechnologies Are in the Spotlight Insider Monkey
08:00AM  Why Valeant, Tesla, Citrix Systems, Ruby Tuesday, and Stellar Biotechnologies Are in the Spotlight at Insider Monkey
Mar-13-17 05:02PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Other Events, Finan
04:55PM  Stellar Biotechnologies and Matrivax Sign Agreement to Transfer Vaccine Technology PR Newswire
Mar-06-17 08:45AM  The Life Sciences Report Examines Stellar Biotechnologies (SBOT:NASDAQ) Inking Multiyear KLH Supply Agreement with Amaran Biotechnology; Stellar Up 27% on News Marketwired
Mar-02-17 09:00AM  The Life Sciences Report Examines How Stellar Biotechnologies Could Rise with KLH Vaccine Trial Success Marketwired +8.12%
Mar-01-17 07:30AM  Amaran Biotechnology Selects Stellar KLH for Cancer Vaccines PR Newswire
Feb-10-17 01:04PM  STELLAR BIOTECHNOLOGIES, INC. Financials -7.22%
Feb-09-17 08:15AM  SBOT: Q1 Light On Revenue But Clinical Trial Progression Suggests Growth Ahead Zacks Small Cap Research +5.88%
08:15AM  Q1 Light On Revenue But Clinical Trial Progression Suggests Growth Ahead
Feb-07-17 06:05AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
Feb-06-17 07:15PM  Stellar Biotechnologies Reports First Quarter 2017 Financial Results PR Newswire
05:27PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 10-Q, Quarterly Report
07:30AM  Stellar Biotechnologies Congratulates Partner's Decision to Extend Drug Development for Diabetes PR Newswire
Jan-11-17 07:30AM  Stellar Biotechnologies Advances Strategic Plan to Secure Key Production Region Marketwired
Jan-04-17 07:30AM  Stellar Biotechnologies to Present at Biotech Showcase Conference Marketwired
Dec-19-16 03:00PM  SBOT: 2016 A Solid Year, Both Financially and Operationally
08:24AM  Stellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: 2016 By the Numbers : December 19, 2016
Dec-14-16 04:22PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:05PM  Stellar Biotechnologies Reports Fiscal Year 2016 Financial Results Marketwired
Dec-12-16 07:45AM  Stellar Biotechnologies Announces Fiscal Year 2016 Corporate Update Conference Call Marketwired
Dec-09-16 08:01AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial
07:45AM  Stellar Biotechnologies Appoints Pharma and Capital Markets Experts to Board of Directors Marketwired
Dec-07-16 04:09PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Dec-01-16 07:45AM  Stellar Biotechnologies to Present at the LD Micro Main Event Investor Conference Marketwired +12.63%
Oct-24-16 09:28AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
07:30AM  Stellar Board Member and Pharma Expert to Join Executive Team Marketwired
Oct-05-16 08:30AM  Stellar Appoints Investor Relations Executive to Management Team to Support Its Continuing Scale-Up Marketwired
Oct-04-16 07:00AM  VistaGen Therapeutics Appoints Mark A. McPartland Vice President of Corporate Development and Investor Relations PR Newswire -9.02%
Sep-27-16 04:31PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Sep-21-16 08:30AM  Stellar Biotechnologies to Present at International Aquaculture Symposium Marketwired -5.59%
Sep-06-16 08:30AM  Stellar Biotechnologies to Present at the 18th Rodman & Renshaw 2016 Annual Global Investment Conference Marketwired
Aug-11-16 11:29AM  Stellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: Q3, 2016 By the Numbers : August 11, 2016
11:00AM  SBOT Preparing To Scale In Anticipation of Growing Demand
Aug-09-16 08:02AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition
08:00AM  Stellar Biotechnologies Reports Third Quarter 2016 Financial Results and Operational Highlights Marketwired
Aug-04-16 08:30AM  Stellar Biotechnologies Announces Third Quarter 2016 Corporate Update Conference Call Marketwired
Jul-19-16 04:14PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Other Events
08:00AM  Stellar Biotechnologies and Neovacs Announce Formation of New Company Neostell S.A.S. in France Marketwired
02:15AM  Neovacs and Stellar Biotechnologies Announce Launch of Neostell, Joint Venture to Manufacture Kinoids GlobeNewswire
Jul-07-16 06:02AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Other Events +6.65%
Jul-06-16 12:00PM  Stellar Biotechnologies Announces Closing of Registered Direct Offering Marketwired
Jun-30-16 12:42PM  Heres Why Traders Are Buzzing Around Lions Gate, Stellar Biotechnologies, and Three Other Stocks at Insider Monkey -8.61%
09:23AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Eq
08:45AM  Stellar Biotechnologies Announces Pricing of $6.75 Million Registered Direct Offering Marketwired
Jun-23-16 09:00AM  Maxim's Jason McCarthy Interviewed by The Life Sciences Report Marketwired +19.57%
Jun-02-16 08:00AM  Stellar Biotechnologies to Present at LD Micro Invitational Conference Marketwired
May-25-16 11:29AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Other Events
09:00AM  Stellar Biotechnologies Named as a 2016 California Small Business of the Year Marketwired
May-23-16 11:17AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Other Events
08:30AM  Stellar Biotechnologies Appoints Michael L. Klein, Ph.D. as Vice President of Chemistry, Manufacturing and Controls (CMC) Marketwired
May-17-16 04:33PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial
May-16-16 10:30AM  SBOT: JV Consummated, Neovacs' Lupus Candidate Closer to Commercialization
May-12-16 11:32AM  Stellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: Q2, 2016 By the Numbers
02:15AM  Neovacs and Stellar Biotechnologies sign joint venture agreement to create Neostell SAS GlobeNewswire
May-11-16 10:02AM  Stellar Biotechnologies and Neovacs Sign Joint Venture Agreement to Manufacture Conjugated Therapeutic Vaccines With Stellar KLH(TM) Marketwired
May-10-16 06:06AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
May-09-16 06:08PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 10-Q, Quarterly Report +5.57%
05:18PM  Stellar Biotechnologies Reports Second Quarter 2016 Financial Results and Operational Highlights Marketwired
May-03-16 08:30AM  Stellar Biotechnologies Announces Second Quarter 2016 Corporate Update Conference Call Marketwired
Mar-29-16 05:10PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Other Events
05:07PM  Stellar Biotechnologies' Announces Effective Date of TSX-V Voluntary Delisting at noodls
05:00PM  Stellar Biotechnologies' Announces Effective Date of TSX-V Voluntary Delisting Marketwired
Mar-23-16 08:58AM  Stellar Biotechnologies Applies for Voluntary Delisting From TSX Venture Exchange at noodls
08:36AM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Regulation FD Disclosure
08:30AM  Stellar Biotechnologies Applies for Voluntary Delisting From TSX Venture Exchange Marketwired
Mar-22-16 04:32PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders -7.14%
Mar-18-16 04:38PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Mar-09-16 08:30AM  Stellar Biotechnologies to Present at the 28th Annual ROTH Conference Marketwired
Feb-25-16 07:48AM  [$$] Stellar Biotechnologies Gets a Positive Sign at Barrons.com
Feb-11-16 11:06AM  Stellar Biotechnologies, Inc. Earnings Analysis: Q1, 2016 By the Numbers -6.19%
09:45AM  SBOT: Potential Transformative Events in 2016
Feb-08-16 04:38PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition -6.05%
04:15PM  Stellar Biotechnologies Reports First Quarter 2016 Financial Results and Operational Highlights Marketwired
Feb-04-16 08:30AM  Stellar Biotechnologies Announces First Quarter 2016 Corporate Update Conference Call Marketwired
Jan-26-16 03:00PM  SBOT: JV Offers Full Product Life Cycle Opportunity
08:49AM  Stellar Biotechnologies Presents Research on Nanofiltration Development at PepTalk Conference at noodls
08:30AM  Stellar Biotechnologies Presents Research on Nanofiltration Development at PepTalk Conference Marketwired
Jan-21-16 02:15AM  Neovacs Associates Stellar Biotechnologies in Its Industrial Project GlobeNewswire
Jan-20-16 04:04PM  STELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Other Events -9.83%
04:00PM  Stellar Biotechnologies and Neovacs Propose to Form Joint Venture to Manufacture Conjugated Therapeutic Vaccines With Stellar KLH(TM) Marketwired
Jan-08-16 08:30AM  Stellar Biotechnologies to Present at Biotech Showcase 2016 Conference Marketwired -5.79%
Dec-16-15 09:50AM  SBOT: Q4 Inline. 2016 Should Benefit From More, Larger Customer Clinical Trials
Stellar Biotechnologies, Inc., a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein primarily in Europe, the United States, and Asia. KLH is an immune-stimulating protein used for generation of antibody and cell-mediated immune responses against disease indications, such as cancer, immune disorders, Alzheimer's, and inflammatory diseases, as well as used for therapeutic vaccine conjugation in immunotherapies. The company also offers in vitro diagnostic kits for preclinical use. It provides its products under the Stellar KLH brand name. The company serves multinational biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers. Stellar Biotechnologies, Inc. is based in Port Hueneme, California.